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Abstract
Objective—Our objective was to investigate change in prevalence rates for mental and substance
abuse disorders between early adolescence and young adulthood in a cohort of indigenous
adolescents who participated in an 8-year panel study.
Method—The data are from a lagged, sequential study of 671 indigenous adolescents (Wave 1)
from a single culture in the Northern Midwest USA and Canada. At Wave 1 (mean age 11.3 years,
Wave 4 (mean age 14.3 years), Wave 6 (mean age 16.2 years), and at Wave 8 (mean age 18.3
years) the tribally enrolled adolescents completed a computer-assisted personal interview that
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included DISC-R assessment for 11 diagnoses. Our yearly retention rates by diagnostic wave
were: Wave 2, 94.7 %; Wave 4, 87.7 %; Wave 6, 88.0 %; Wave 8, 78.5 %.
Results—The findings show a dramatic increase in lifetime prevalence rates for substance use
disorders. By young adulthood, over half had met criteria of substance abuse or dependence
disorder. Also at young adulthood, 58.2 % had met lifetime criteria of a single substance use or
mental disorder and 37.2 % for two or more substance use or mental disorders. The results are
compared to other indigenous diagnostic studies and to the general population.
Conclusions—A mental health crisis exists within the indigenous populations that participated
in this study. Innovations within current mental health service systems are needed to address the
unmet demand of adolescents and families.
Keywords
American Indian; Mental health; Indigenous adolescents; Substance abuse; Psychiatric disorder
Introduction
Although there have been recent large psychiatric epidemiological studies of American
Indian (AI) adults [1], there have been just three published psychiatric diagnostic studies
that included AI children and adolescents and some are now decades old. The best known is
the Great Smoky Mountains Study (GSMS) which compared 323 Cherokee children aged 9,
11, and 13 years to 933 similarly aged European American children [2]. The AI children
were slightly less likely than European American (EA) children to meet criteria for a
psychiatric disorder; however, the AI children were significantly more likely to meet criteria
for substance abuse disorder (SUD) (1.2 %) than their EA counterparts (0.1 %). The second
study was of 109 Northern Plains AI adolescents aged 14–16 years (mean = 15.6 years) [3].
The Northern Plains adolescents were more likely than EA adolescents to meet 6-month
criteria for attention deficit/hyperactivity disorder (ADHD), SUD, and conduct disorders
(CD), but had similar or lower rates of major depressive episode (MDE) and anxiety
disorders.
The third published study was our analyses of the first two diagnostic waves of the current
longitudinal study of 746 Northern Midwest indigenous adolescents (i.e., AI and Canadian
First Nations adolescents) [4]. We reported a dramatic increase in the prevalence of
psychiatric disorders between early (mean age 11.1 years) and mid-adolescence (mean age
14.3 years). The increases were particularly pronounced for SUDs and disruptive behavior
disorders. At mid-adolescence, the 12-month prevalence rates for SUDs were three times
those reported in the National Survey of Drug Use and Health and rates for lifetime conduct
disorder were more than twice those in the general population.
Such early onset of SUDs and psychiatric disorders is associated with emerging comorbidity
during adolescence [5] and portend psychiatric and substance use problems that can reach
into adulthood [6, 7]. The research reported here empirically addresses these trajectories into
late adolescence (mean age 16.2 years) and early adulthood (mean age 18.3 years). It is the
only longitudinal study of onset of psychiatric and substance use disorders among
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indigenous (American Indian and Canadian First Nations) youth from early adolescence
through young adulthood.
Method
Procedures
Yearly interviews were conducted with an adolescent and at least one primary caretaker on
four reservations in the Northern Midwest US and four Canadian First Nations reserves.
There was a 1-year lag between study sites for data collection. Three Canadian reserves and
one US reservation were added to the study 1 year after the first cohort was interviewed at
three US reservations and one Canadian reserve. The interviews continued in a 1-year
lagged sequence through the eight waves of data collection. After Wave 1, to reduce subject
burden, the subsequent Waves 4, 6 and 8 were reserved for diagnostic interviews only.
Therefore, we have diagnostic information for Wave 1 (mean age 11.1 years), Wave 4
(mean age 14.3 years), Wave 6 (mean age 16.2 years), and Wave 8 (mean age 18.3 years).
We present the findings by diagnostic wave.
The research team was invited to work on these reservations/reserves by tribal councils and
tribal resolutions were obtained from each reservation/reserve. As part of our agreement to
work together, the researchers agreed that participating reservations/reserves would be kept
confidential in published reports. These reservations/reserves did not have organized human
subjects review boards, so the advisory boards appointed by the tribal councils performed
this function. Once we had advisory board consensus across all of the reservations/reserves,
the study procedures and questionnaires were submitted to the university institutional review
board for clearance for ethically appropriate research with human subjects.
Participants
A population sample of 746 tribally enrolled adolescents aged 10–12 years (average age
11.3 years) and 971 of their parents/caretakers was recruited to participate in an eight-wave
panel study conducted from 2002 to 2010 with diagnostic interviews at Waves 1, 4, 6, and 8.
The overall initial response rate was 79.4 %. Yearly retention rates for the diagnostic waves
were: Wave 4, 87.7 %; Wave 6, 88.0 %; and Wave 8, 78.5 %. Reservation/reserve advisory
boards approved all manuscripts prior to submission for publication. The sample reported on
here was reduced from that in previously published reports, in that one US reservation
advisory board dissolved and therefore could not read and approve this paper. The loss of
the approximately 70 cases from this reservation did not significantly change the results of
these analyses. For this report, the diagnostic sample at Wave 1 consisted of 672 adolescents
(334 males and 337 females).
Eligibility
Each reservation/reserve provided a list of families of tribally enrolled children aged 10–12
years. We attempted to contact all families with an enrolled child within the specified age
range who lived on or proximate to (within 50 miles) the reservation or reserve. Children in
foster care or staying with relatives other than their biological parents were not excluded
from the study. Families were recruited through a personal visit by an indigenous
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interviewer at which time the project was explained to them. On the advice of elders on the
advisory boards, the families were presented with a small traditional gift as a gesture of
respect for giving their time when they were invited to participate. If they agreed to be
interviewed, the study child and at least one caretaker each received $40 for their time when
the interviews were completed.
Interviewer training
All of the interviewers on the reservations/reserves were approved by the advisory boards
and were either tribal members or, in a very few cases (4 out of approximately 45
interviewers), non-members who were spouses of tribal members. The families were given
the opportunity to decline particular interviewers if they were related to them or if they were
otherwise uncomfortable with the interviewer. Each reservation/reserve had a local
indigenous full-time interviewer supervisor who coordinated visits and provided quality
control. To ensure quality of data collection, all the interviewers underwent special training
for conducting computer-assisted personal interviewing (CAPI) for the diagnostic measures.
The training took place on-site over a period of 3 days and included practice interviews and
feedback sessions regarding interview quality. Prior to each wave of data collection, each
interviewer submitted four practice diagnostic interviews for feedback. All of the
interviewers completed annual required human subjects’ protection training. The training
emphasized the importance of confidentiality and taught procedures to maintain the
confidentiality of data.
Measures
Child diagnostic information was obtained for 11 diagnoses. The substance abuse disorders
(alcohol abuse, alcohol dependence, marijuana abuse, marijuana dependence, nicotine
dependence, other substance use/dependence), major depressive disorder, dysthymic
disorder, generalized anxiety disorder, oppositional defiant disorder, conduct disorder, and
attention deficit hyperactivity disorder modules were assessed using the Diagnostic
Interview Schedule for Children-Revised (DISC-R). The diagnoses were based on
algorithms for the Diagnostic and Statistical Manual-IV-TR [8]. Cultural sensitivity
regarding any measures that would identify child maltreatment prohibited administering the
posttraumatic stress disorder module.
The DISC-R is a highly regarded, structured interview intended for use with trained
interviewers. The DISC-R has been used extensively for children aged 11 years and older [9,
10]. Test–retest reliability for self-reports of children under 11 years of age varies by
diagnostic category, with younger children being particularly unreliable reporters of onset
and duration of symptoms. Reliability research on various versions of the DISC indicate that
parent reports are the most reliable and that combined parent–child reports are more reliable
than child reports alone [11–13]. Jensen and colleagues [14] argue that although discrepant
caretaker and child reports provide meaningful information in some cases (e.g., attention
deficit hyperactivity disorder), child reports should be treated cautiously. We have reported
combined caretaker and child reports elsewhere. [7, 15, 16] For ease of comparison of
prevalence estimates across the four waves of date, we report only the adolescent reports for
meeting diagnostic criteria. For this reason, the Wave 1 prevalence rates should be accorded
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proper caution. By Wave 4, the adolescents averaged 14.3 years, at Wave 6, 16.2 years, and
at Wave 8, 18.3 years.
Impairment
For each disorder at Waves 6 and 8, adolescents were asked six questions to assess levels of
impairment. Response categories for some of the impairment questions were “a lot of the
time,” “some of the time,” and “hardly ever,” and for others, “very bad,” “bad,” and “not too
bad.” As we did in our 2008 report [7], we calculated impairment ratings using the following
criteria: (1) adolescents were given an intermediate impairment rating if they gave a
response of “some of the time” or “bad” to at least one of the questions, and (2) adolescents
were given a severe impairment rating if they gave a response of “a lot of the time” or “very
bad” to at least one question. If an adolescent was both intermediately and severely
impaired, he/she was classified as only severe to make the rating categories mutually
exclusive for individual disorders.
Results
Sample characteristics
The mean per capita family income was $5,522. Approximately, 32.6 % of the adolescents
resided with a single parent. Among parents/caretakers, 20.6 % had less than a high school
education, 41.2 % had a high school diploma or GED, and 38.2 % had at least some college
education.
Breakdown of diagnoses across the four diagnostic data points (Waves 1, 4, 6, and 8)
Table 1 presents diagnostic prevalence by study wave (confidence intervals for Waves 6 and
8 are presented in Appendix).
One or more psychiatric or substance use disorders
By Wave 8, over one-half (58.2 %) of the adolescents had met criteria for at least one
psychiatric disorder and 28.1 % met criteria for a past-year disorder. More than one-third
(37.2 %) met lifetime criteria for two or more disorders at Wave 8. The prevalence of two or
more past-year disorders increased from Wave 1 (4.8 %) to Wave 4 (16.1 %) where they
plateaued at Wave 6 (16.7 %) then declined at Wave 8 (11.8 %).
Alcohol/substance use disorders
At Wave 8, the most prevalent lifetime young adult diagnostic category was alcohol and
substance use disorder (51.0 %). The most frequent lifetime substance use disorder was
alcohol abuse (32.7 % at Wave 8) followed by marijuana dependence (23.7 %), nicotine
dependence (19.3 %), and alcohol dependence (17.6 %). At Wave 8 there was very little
lifetime abuse (1.2 %) or dependence (1.9 %) of other substances (i.e., substances other than
alcohol, nicotine, or marijuana).
Past-year rates of substance abuse and dependence disorders increased between Waves 1
and 4, leveled off between Waves 4 and 6, and declined between Waves 6 and 8. There was
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a decline in past-year alcohol dependence (5.2 vs 4.2 %), nicotine dependence (7.9 vs 5.0
%), and marijuana dependence (10.0 vs 7.4 %) between Waves 6 and 8.
Internalizing disorders
We found very low rates of internalizing disorders. At Wave 8, only 1.5 % of the young
people met past-year criteria for major depressive disorder (MDD), down from 4.6 % at
Wave 6. Only 1.0 % of the adolescents were currently depressed (past month) at Wave 8
compared to 1.9 % at Wave 6. Less than 1 % met past-year criteria for generalized anxiety
disorder (GAD) or dysthymic disorder (DD).
Attention deficit/hyperactivity disorder
The prevalence rates of past-year attention deficit/hyper-activity disorder (ADHD) were low
across waves, ranging from 2.5 % at Wave 1 and declining to 1.4 % at Wave 6, and 1.0 % at
Wave 8.
Disruptive behavior disorders
The number of adolescents meeting criteria for past-year oppositional defiant disorder
(ODD) decreased between Wave 4 (4.4 %), Wave 6 (3.5 %), and Wave 8 (1.7 %).
Adolescent-reported lifetime conduct disorder (CD) increased linearly across the diagnostic
waves from 7.6 % at Wave 1 to 32.1 % at Wave 8. Although lifetime CD increased across
time, current CD (past year) declined after peaking at 12.1 % at Wave 4 (average age 14.3
years). At Wave 6, 9.0 % of the adolescents met past-year criteria for CD; this further
decreased to 1.3 % at Wave 8.
Past-year and lifetime comorbidity
We assessed 12-month comorbidity at Wave 6 when 12-month prevalence was highest
(Table 2). The adolescent males who met criteria for past-year SUD at Wave 6 were more
likely also to meet criteria for CD (30.9 %) than were adolescent females (17.7 %). The
SUD females, on the other hand, were more likely to also meet criteria for MDD (12.8 %)
than males (6.2 %). The majority of adolescent males (75.8 %) and females (85.0 %) who
met the criteria for past-year CD also met criteria for SUD. Very few adolescents met
criteria for both CD and MDD, but young women with CD were more likely also to be
depressed (6 females, 33.3 %) than the young men with CD (3 males, 9.1 %). Among the
adolescents who met past-year criteria for MDD, 5 of the males (55.6 %) and 12 of the
females (66.7 %) also met past-year criteria for SUD. Three males with MDD and six
females with MDD also met past-year criteria for CD.
Tests for gender differences
We tested for gender differences among diagnostic groups of lifetime disorders: alcohol
substance use disorders, disruptive behavior disorders, at least one disorder, and two or more
disorders. The only statistically significant gender difference was at Wave 6 where the
adolescent males were more likely to meet criteria for disruptive behavior disorders than
adolescent females.
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Impairment
Impairment ratings were calculated for only those adolescents who met past-year criteria for
each disorder. Of the young people who met past-year criteria for alcohol dependence at
Wave 8, 40.9 % indicated that they were severely impaired and 45.5 % indicated
intermediate impairment (see Table 3). Almost one-half of those who met criteria for
marijuana dependence at Wave 8 reported intermediate (23.1 %) or severe (23.1 %)
impairment. Of the four adolescents who met criteria for GAD at Wave 8, one reported
intermediate impairment and three severe impairment. At Wave 6, 27 of the adolescents who
met criteria for MDD indicated impairment, 40.7 % reported intermediate and 48.1 % severe
impairment. Two years later (Wave 8), five (62.5 %) of the eight young adults who met
criteria for MDD reported severe impairment and the remaining three (37.5 %) reported
intermediate impairment. At Wave 6, two (25 %) of the eight adolescents who met criteria
for ADHD indicated that they were severely impaired by inattention and five (62.5 %)
reported that they were severely impaired by hyperactivity. In addition, four (50 %) of the
adolescents were intermediately impaired by inattention and one (12.5 %) by hyperactivity.
Among those who met criteria for CD at Wave 6 (N = 53), 34.0 % indicated that they were
severely impaired and 37.7 % were intermediately impaired.
At Wave 6, of those who met criteria for any single diagnosis, about two-thirds (62.9 %)
were intermediately impaired and more than one-half (56.4 %) were severely impaired. The
general trend was for decreasing impairment at young adulthood. At Wave 8, among those
with caseness for any single diagnosis, 53.1 % were intermediately impaired and 38.1 %
were severely impaired. Those with comorbid disorders reported high levels of impairment
at both Waves 6 and 8. At Wave 6, among adolescents with two or more disorders, 77.8 %
were intermediately impaired and 65.7 % were severely impaired. Among young adults
(Wave 8) with comorbid disorders, 57.6 % were intermediately impaired and 59.3 % were
severely impaired.
Placing the results in context
To place the results in the context of other epidemiological studies of indigenous people, we
compared Wave 6 (mean age 16.2 years) and Wave 8 (mean age 18.3 years) young people
and their adult parent/caregiver prevalence rates [17] to other studies of AI adolescents and
adults (Table 4). There are no perfectly comparable studies matching diagnostic categories
and age ranges; however, five published reports provide some perspective for our findings.
(1) Beals and colleagues [3] used the Diagnostic Interview Schedule for Children, Version
2.1C, to assess 109 American Indian adolescents from a Northern Plains tribe. (2) The
American Indian Service Utilization, Psychiatric Epidemiology, Risk and Protective Factors
Project (AI-SUPERPFP) surveyed 15- to 54-year-old American Indians from two
reservation populations [1]. This is a stratified random sample of tribally enrolled
individuals from two Northern Plains tribes (n = 1,638) and one Southwest tribe (1,446). (3)
The Great Smoky Mountains Study (GSMS) is a longitudinal, population-based study which
included 1,420 participants who were interviewed multiple times between the ages of 9 and
21 years [2]. Our comparisons are for respondents interviewed at age 21 years. Although
American Indians were oversampled in the GSMS, they were not reported separately. (4)
Two reports from the National Comorbidity Survey Replication (NCS-R) provide
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comparisons to the general population (n = 9,282), because lifetime and 12-month
prevalence were reported in separate publications [18, 19]. The comparisons are most
applicable to our Wave 8 young adults. We included the Wave 6 adolescents to make the
point that psychiatric diagnoses appeared to have peaked early among our study participants.
We included the few diagnoses we had for the study parent/caretakers to provide
intergenerational comparisons between the adolescent and parent generation.
Substance use disorders
At Wave 8, the Northern Midwest (NMW) adolescents had higher lifetime prevalence rates
of SUD (51.0 %) than participants in the AI-SUPERPFP Northern Plains sample (37.0 %),
even though the age range for AI-SUPERPFP was much wider (15–54 years). Prevalence of
lifetime SUD among the NMW adolescents also was higher than the rates from the National
Comorbidity-Replication (NCS-R) (14.6 %). Current SUD (12-months for NMW, 6 months
for Beals et al.) was higher among the NMW adolescents (29.9 %) than for Beals and
colleagues’ sample of Northern Plains adolescents (18.3 %) and AI-SUPERPFP (17.5 %,
Northern Plains; 10.5 % Southwest). The Wave 8 adolescents’ lifetime SUD (51.0 %) was
already approaching that of their parent generation (69.4 %).
At Wave 8 with an average age of about 18 years, the prevalence of lifetime alcohol
dependence (17.6 %) was similar to lifetime rates of their parents/caretakers (19.6 %) and to
AI-SUPERPFP Northern Plains people aged 15 years and older (16.6 %). At Wave 6,
prevalence rates for combined marijuana dependence plus abuse were about twice those of
the Beals and colleagues’ Northern Great Plains sample (16.2 vs 8.6 %). However, the
NMW adolescents reported less abuse or dependence of substances other than alcohol or
marijuana at Wave 8 (1.3 %) than those in the Beals and colleagues sample (3.9 %).
Internalizing disorders
The NMW adolescents had very low rates of past-year generalized anxiety disorder (GAD)
(0.3 %, Wave 6) compared to their parents/caretakers (3.2 %), Northern Plains (1.0 %) and
Southwest (1.8 %) AI people. In fact, all of the indigenous samples had lower GAD rates
than those reported in the general population (5.7 %).
Twelve-month major depressive disorder (MDD) among the NMW adolescents at Wave 6
(4.6 %) was similar to the past-month MDD reported by Beals et al. (4.7 %) and to past-year
prevalence among Northern Plains (4.3 %) and Southwest AI adults (6.5 %). Prevalence for
MDD dropped dramatically among the NMW adolescents in Wave 8 (1.5 %). Past-year
MDD among the NMW parent generation (8.1 %) was much higher than their Wave 6 or
Wave 8 offspring, perhaps indicating adult onset.
Attention deficit/hyperactivity disorder
Past-year ADHD among the NMW adolescents (1.4 %) was much lower than that reported
by Beals et al. (10.6 %), but very similar to that reported by Costello and colleagues [2] in
the Great Smokey Mountain Study (Wave 1; 1.2 %, not shown).
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Disruptive behavior disorders
Rates of past-year CD were 7.8 % for the Wave 6 NMW adolescents compared to 3.8 % in
the Beals et al., Northern Great Plains; and Costello et al., GSMS, 6.5 % (not shown). The
prevalence of past-year NMW CD dropped dramatically between Waves 6 and 8.
Prevalence rates across diagnoses
At Wave 6, approximately one-half (51.4 %) of the adolescents met criteria for at least one
disorder. This had increased to 58.2 % by Wave 8, approaching the lifetime rates of their
parents/caretakers (71.8 %) and slightly exceeding the rates for a single psychiatric disorder
in general population studies (46.4 %). This is congruent with other research that indicates
the adolescent onset of most psychiatric disorders [18]. Approximately, one-third of the
NMW young adults (37.2 %) and their parents/caretakers (37.0 %) met criteria for two or
more lifetime disorders. Again, the prevalence rate for comorbid disorders is higher than
comorbidity rates found in the general population (27.7 %).
Discussion
We see a pattern of early-onset behavioral disorders (primarily conduct disorder) that
emerge prior to SUDs until mid-adolescence, at which point new cases of SUD accelerate
and behavioral disorders essentially plateau. Disruptive behavior disorders and SUDs
account for much of the early psychopathology as opposed to internalizing disorders, such
as generalized anxiety disorders and mood disorders. Moreover, disruptive behavior
disorders are highly comorbid with SUDs, perhaps a consequence of emerging earlier. Our
findings are congruent with years of earlier work showing early onset of substance abuse
among indigenous adolescents [20–22], but they extend these findings to the diagnostic level
for early onset of SUDs. Kessler [18] has pointed out that SUDs are often the last diagnoses
to emerge, usually in the early twenties. For these adolescents, SUDs emerge much earlier.
Our results also refine previous findings by demonstrating the interrelationship of early
behavioral disorders and SUDs.
There were few new diagnoses after an average age of about 16 years. Lifetime prevalence
rates peaked at an average age of 16.2 years (Wave 6) and leveled off at an average age of
18.3 years (Wave 8). This is particularly apparent with regard to past-year prevalence rates.
In nearly all of the diagnostic categories there was a decline in past-year prevalence between
Waves 6 and 8. This was most evident for disruptive behaviors (e.g., CD, ODD) and to a
lesser extent the SUDs. Meeting criteria for any past-year disorder declined from 34.1 % at
Wave 6 to 28.1 % at Wave 8, and for two or more past-year disorders from 16.7 to 11.3 %.
The patterns of impairment suggest that the diagnoses seriously affect the life of the
adolescents. This is particularly true for alcohol dependence where at Wave 8, 40.9 %
reported severe impairment and 45.5 % intermediate impairment. Although there were few
cases of generalized anxiety disorder and major depressive disorder in the later waves of the
study, the adolescents who met criteria for these diagnoses tended to rate their symptoms as
severe. In general, those meeting criteria for a single disorder in Wave 8 were more likely to
Whitbeck et al. Page 9
Soc Psychiatry Psychiatr Epidemiol. Author manuscript; available in PMC 2015 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
rate their symptoms as intermediate (53.1 %) than severe (38.1 %). Those with two or more
disorders were more likely to report severe symptoms (59.3 %).
Like most studies that focus on indigenous children and adolescents, this research was
limited to a single culture. The results may not be generalizable to other indigenous cultures
and perhaps not even to urban indigenous people in this same culture. Diagnostic
measurement is also a concern [23]. It is possible that behavioral measures such as those for
SUD and disruptive behaviors are more valid in this culture than measures pertaining to
feelings and emotional states. This may account for our low rates of mood and anxiety
disorders. This is a non-trivial concern that suggests cross-cultural differences in
internalization disorders may be affected by culturally insensitive or inappropriate measures,
an area that that we believe needs increased scrutiny [24]. Regardless of whether we are
underestimating internalizing disorders, the prevalence and early onset of externalizing
disorders and SUDs have important policy and prevention implications.
Also, this is a community-based participatory research. Almost all of the interviewers were
conducted by enrolled tribal members from the participating communities. Although the
families were given the opportunity to decline particular interviewers if they were related to
them or if they were otherwise uncomfortable with the interviewer, local interviewers may
have resulted in underreporting and may have introduced a conservative bias.
There is the additional concern that at Wave 8 we continued to use the diagnostic criteria for
CD for adolescents who had become older than 18 years. This calls into question the age
appropriateness of the CD diagnoses. Only seven (7.3 %) of the Wave 8 young people met
past-year criteria for CD. Six of the seven were aged 17 or 18 years; only one was aged 19
and this individual had met criteria for past-year CD in previous waves. For lifetime CD, all
of the young people over the age of 18 years who met lifetime criteria had met criteria in
previous waves. No new cases of CD emerged after 18 years.
A final concern is the small decrease in prevalence rates for some diagnoses between Wave
6 and 8 (Table 1). The decreases across age cohorts (Table 1) are the result of the timing of
the interviews. Diagnostic interviews were not conducted at every wave of data collection,
but rather at Waves 1, 4, 6, and 8. At Wave 1 the adolescents were between the ages of 10
and 13 years. Because of the timing of subsequent interviews across a changing age range of
the adolescents, we do not have estimates of mental and substance use disorders at every age
for each adolescent.
Conclusions
The strong linkages between disruptive behavior disorders and SUDs suggest that indexed
behavioral interventions should begin in early childhood when they are first identified.
Based on our results, we would argue for two levels of interventions. First, we recommend
very early and ongoing indexed interventions directed at early childhood behavioral
problems. Second, because early use is the strongest predictor of meeting criteria for alcohol
dependence during adolescence [18], we recommend universal prevention programs
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beginning at pre-adolescence and repeated throughout early adolescence with the goal of
delaying early experimentation and transition to regular use.
We should note that the findings reflect evidence of adolescent resilience and some cause
for optimism. Although we have lingering concerns about measurement of internalizing
disorders among indigenous people, the rates of internalizing disorders are very low. Also,
the low rates of substance abuse other than nicotine, alcohol, and marijuana indicate
adolescents have not progressed to harder drug use. Finally, the decrease in past-year
diagnoses in Wave 8 may reflect emergence of healthier young adults after a period of mid-
adolescent problems.
In summary, we found a peak in behavioral disorders in mid-adolescence and escalating
SUDs into young adulthood. Of primary concern is that these adolescents are beginning to
use substances early and their use is to such a degree that they are meeting diagnostic
criteria. This is a serious public health issue that portends long-term consequences. The
problem has been documented now at multiple levels [20–22]. There remains an urgent need
for research that addresses the specific mechanisms at work that account for the early-onset
SUDs and disruptive behavior disorders among indigenous adolescents. Finally, our findings
regarding the late adolescent–early adulthood leveling off of new diagnoses needs
replicating, to be certain this finding was not a design or measurement artifact.
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Appendix
See Appendix Table 5
Table 5
Confidence intervals for the prevalence of DSM-IV disorders, Waves 6 and 8
Lifetime/past year/past month (%) Wave 6 (N = 592) (mean age 16.2) Wave 8 (N = 524) (mean age 18.3)
% CI % CI
Alcohol/substance use disorders
 LT 42.2 [38.2, 46.2] 51.0 [46.7, 55.3]
 PY 29.9 [26.2, 33.6] 25.8 [22.0, 29.5]
Alcohol abuse
 LT 24.7 [21.2, 28.1] 32.7 [28.7, 36.7]
 PY 16.9 [13.9, 19.9] 15.3 [12.2, 18.4]
Alcohol dependence
 LT 14.5 [11.7, 17.4] 17.6 [14.3, 20.8]
 PY 5.2 [3.4, 7.04] 4.2 [2.5, 5.9]
Nicotine dependence
 LT 16.7 [13.7, 19.7] 19.3 [15.9, 22.7]
 PY 7.9 [5.7, 10.1] 5.0 [3.1, 6.8]
Marijuana abuse
 LT 12.8 [10.1, 15.5] 16.8 [13.6, 20.0]
 PY 6.3 [4.3, 8.2] 4.0 [2.3, 5.7]
Marijuana dependence
 LT 18.9 [15.8, 22.1] 23.7 [20.0, 27.3]
 PY 10.0 [7.6, 12.4] 7.4 [5.2, 9.7]
Other substance abuse
 LT 1.0 [0.2, 1.9] 1.2 [0.2, 2.1]
 PY 0 [0.0, 0.0] 0 [0.0, 0.0]
Other substance dependence
 LT 1.5 [0.5, 2.5] 1.9 [0.7, 3.1]
 PY 1.0 [0.2, 1.9] 1.4 [0.4, 2.4]
Generalized anxiety disorder
 PY 0.3 [0.0, 0.8] 0.8 [0.0, 1.5]
 PM 0.2 [0.0, 0.5] 0.6 [0.0, 1.2]
Mood disorders
 PY 4.9 [3.2, 6.6] 2.1 [0.9, 3.3]
 PM 1.9 [0.8, 3.0] 1.0 [0.1, 1.8]
Major depressive disorder
 PY 4.6 [2.9, 6.3] 1.5 [0.5, 2.6]
 PM 1.9 [0.8, 3.0] 1.0 [0.1, 1.8]
Dysthymic disorder
 PY 0.3 [0.0, 0.8] 0.6 [0.0, 1.2]
 PM 0 [0.0, 0.0] 0 [0.0, 0.0]
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Lifetime/past year/past month (%) Wave 6 (N = 592) (mean age 16.2) Wave 8 (N = 524) (mean age 18.3)
% CI % CI
Attention deficit/hyperactivity and disruptive behavior disorders
 LTa 31.9 [28.2, 35.7] 33.4 [29.4, 37.5]
 PY 10.3 [7.9, 12.8] 3.6 [2.0, 5.2]
 PM 8.8 [6.5, 11.1] 2.5 [1.1, 3.8]
Attention deficit/hyperactivity disorder
 PY 1.4 [0.4, 2.3] 1 [0.0, 1.8]
 PM 1.0 [0.2, 1.8] 0.02 [0.0, 0.1]
Oppositional defiant disorder
 PY 3.5 [2.1, 5.0] 1.7 [0.1, 2.8]
 PM 2.4 [1.1, 3.6] 1.1 [0.0, 2.1]
Conduct disorder
 LT 31.4 [27.7, 35.2] 32.1 [28.1, 36.1]
 PY 9.0 [6.7, 11.3] 1.3 [0.0, 2.3]
At least one disorder
 LTb 51.4 [47.3, 55.4] 58.2 [54.0, 62.4]
 PY 34.1 [20.3, 38.0] 28.1 [24.2, 31.9]
Two or more disorders
 LTb 32.1 [28.3, 35.9] 37.2 [33.1, 41.4]
 PY 16.7 [13.7, 19.7] 11.3 [8.5, 14.0]
LT lifetime, PY past year, PM past month
a
Lifetime (conduct disorder) + past year (attention deficit/hyperactivity disorder and oppositional defiant disorder)
b
Lifetime (all alcohol/substance use disorders and conduct disorder) + past year (generalized anxiety disorder, mood
disorders, attention deficit/hyperactivity disorder, and oppositional defiant disorder)
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